About the Test: Deoxypyridinoline (DPD) is a specific marker of bone collagen breakdown. Urinary DPD measurement helps assess the rate of bone resorption and can be useful in evaluating and monitoring conditions associated with increased bone turnover.
Why is it Done?
Assessment of increased bone resorption
Support in the evaluation of osteoporosis and metabolic bone disorders
Monitoring response to anti-resorptive therapy
Assessment of bone turnover when clinically indicated
Sample Requirement:
Urine sample, preferably as instructed by the laboratory
Follow laboratory-specific collection and handling instructions
Clinical Significance: Increased DPD levels may indicate increased bone resorption and bone turnover. Results should be interpreted along with clinical findings and other investigations such as bone mineral density and relevant biochemical markers.
Note: Test interpretation should be done by a qualified healthcare professional.